Germany Diabetes Device Overview
The market for diabetic devices in Germany is one that is changing quickly due to rising diabetes prevalence and rising demand for cutting-edge management and monitoring tools. The nation is proud of its strict reimbursement laws and comprehensive healthcare system, which promote technological innovation and uptake. Prominent firms in the industry, including as Abbott, Medtronic, and Roche, provide a variety of products, such as blood glucose meters, insulin pumps, and continuous glucose monitors (CGMs).Current patterns point to a move toward digital health solutions that improve patient interaction and enable distant monitoring, such telemedicine and smartphone apps. Growth in the market is further supported by the German government's emphasis on preventative care and the management of chronic diseases. The use of artificial intelligence and data analytics into device functionality is anticipated to revolutionize treatment techniques and greatly enhance patient outcomes as diabetes care becomes more individualized.
The German Diabetes Centre (DDZ) estimates that 8.5 million Germans suffer from diabetes. Over the next 20 years, the number of persons in Germany who have Type 2 diabetes will rise. Up to twelve million people may experience metabolic diseases by 2040, according to DDZ research.
Growth Drivers for the Germany Diabetes Device Market
Insulin delivery device technology has advanced, enabling safer and more precise insulin administration.Diabetes care is being completely transformed by technological developments in insulin delivery systems, smart gadgets, and continuous glucose monitoring (CGM). A growing number of patients wanting improved control over their condition are drawn to diabetes care because to these developments, which improve accuracy, ease, and user experience.
The first and only infusion set that may be worn for up to seven days, the Medtronic Extended infusion set was introduced by Medtronic in a few European countries in April 2021. A set change is usually necessary for an infusion set, which is a tubing that transports insulin from the pump to the body every few days. With this breakthrough, patients can safely continue on insulin pump therapy with fewer interruptions and insertions while also enjoying greater convenience and comfort in their diabetes management routine. An infusion set can now be worn for twice as long. All MiniMed insulin pumps from the 600 and 700 series are compatible with this set.
Placing Personalized Medicine Foremost
Personalized medicine is revolutionizing diabetes care by applying artificial intelligence and data analytics to therapeutic techniques. Healthcare professionals can adapt insulin dosages and monitoring techniques with tailored treatment plans to each patient's unique requirements, lifestyle, and genetic makeup. Better health results result from this individualized strategy, which increases patient involvement and adherence. Furthermore, continuous data collection and real-time insights are made possible by the integration of cutting-edge technologies into diabetes devices, which helps to further improve treatment approaches. The market is expanding as a result of the increasing adoption and usage of these cutting-edge gadgets as patients experience better condition management.Germany Diabetes Device Company Analysis
The major participants in the Germany Diabetes Device market includes Abbott Laboratories, Roche, Dexcom Inc., Medtronic, Novo Nordisk A/S, Eli Lilly, Sanofi.Germany Diabetes Device Company News
In February 2024, Germany has seen the release of Dexcom's real-time continuous glucose monitoring (CGM) device, the Dexcom ONE+. This device enhances comfort and convenience for diabetes treatment by enabling users to wear the sensor in three different body locations and continuously check their blood sugar levels.In May 2023, in a study published in Diabetes Therapy, LifeScan IP Holdings, LLC examined real-world data from a mobile app and blood glucose meter that were enabled via Bluetooth. The study looked at long-term outcomes over a period of 180 days and offered insightful information for people with diabetes.
Types - Industry is divided into 4 viewpoints:
1. Self-Monitoring Devices2. Continuous Glucose-Monitoring Devices
3. Insulin Pumps
4. Insulin Pens
End User - Industry is divided into 3 viewpoints:
1. Hospitals2. Diagnostics Centers
3. Homecare
All companies have been covered with 5 Viewpoints
1. Overviews2. Key Person
3. Recent Developments & Strategies
4. Product Portfolio & Product Launch in Last 1 Year
5. Revenue
Company Analysis
1. Abbott Laboratories2. Roche
3. Dexcom Inc.
4. Medtronic
5. Novo Nordisk A/S
6. Eli Lilly
7. Sanofi
Key Questions Answered in Report:
1. How big is the Germany Diabetes Device industry?2. What is the Germany Diabetes Device industry growth rate?
3. Who are the key players in Germany Diabetes Device industry?
4. What are the factors driving the Germany Diabetes Device industry?
5. Which Region held the largest market share in the Germany Diabetes Device industry?
6. What segments are covered in the Germany Diabetes Device Market report?
Table of Contents
Companies Mentioned
- Abbott Laboratories
- Roche
- Dexcom Inc.
- Medtronic
- Novo Nordisk A/S
- Eli Lilly
- Sanofi
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | October 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 1.39 Billion |
| Forecasted Market Value ( USD | $ 2.62 Billion |
| Compound Annual Growth Rate | 7.3% |
| Regions Covered | Germany |
| No. of Companies Mentioned | 7 |
